These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 581158)

  • 1. [Alveolar surfactant and experimental diabetes (protective action of citicoline)].
    Iozzo A; Cardellino G; Dalmasso F; Garbagni R
    Arch Sci Med (Torino); 1978; 135(2):181-6. PubMed ID: 581158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Respiratory function and alveolar biological changes under the effect of CDP-choline in pulmonary interstitial pathology: pulmonary fibrosis and sarcoidosis].
    Pacheco Y; Douss T; Pujol B; Revol A; Vergnon JM; Biot N; Brune J; Perrin-Fayolle M
    Rev Pneumol Clin; 1985; 41(2):91-100. PubMed ID: 3839593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Changes in alveolar surfactant in alloxan diabetes].
    Garbagni R; Cardellino G; Dalmasso F; Stratta Monga P
    Minerva Med; 1975 Jun; 66(43):2094-7. PubMed ID: 1173683
    [No Abstract]   [Full Text] [Related]  

  • 4. [Study of fetal alveolar surfactant: possibility of induction].
    Bracaglia R; Bellati U; Serri F; Garzetti GG
    Clin Ter; 1979 Dec; 91(6):593-606. PubMed ID: 44494
    [No Abstract]   [Full Text] [Related]  

  • 5. [Relation between citicoline and pulmonary surfactant. Recent acquisitions in the treatment of respiratory syndromes of the newborn].
    Colombo ML; Dogliani P; Raggi M
    Minerva Pediatr; 1976 Nov; 28(37):2303-10. PubMed ID: 1036757
    [No Abstract]   [Full Text] [Related]  

  • 6. [Controlled study of the administration of CDP-choline to preterm newborn infants with respiratory distress syndrome].
    Valls i Soler A; Sanjurjo P; Vázquez Cordero C
    An Esp Pediatr; 1988 Jun; 28(6):493-6. PubMed ID: 3195851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of oral CDP-choline on experimental withdrawal syndrome.
    Tornos ME; Sacristán A; Ortiz JA
    Arzneimittelforschung; 1983; 33(7A):1018-21. PubMed ID: 6684454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of chronic dyskinesia with CDP-choline.
    Arranz J; Ganoza C
    Arzneimittelforschung; 1983; 33(7A):1071-3. PubMed ID: 6684469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Protective effect of citicoline on renal ischemia].
    Canino V; Segre D
    Minerva Chir; 1980 Mar; 35(6):403-8. PubMed ID: 7374981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of cytidine 5'-diphosphocholine (CDP-choline) on the thermal nociceptive threshold in streptozotocin-induced diabetic mice.
    Kamei J; Ohsawa M; Miyata S; Endo K; Hayakawa H
    Eur J Pharmacol; 2008 Nov; 598(1-3):32-6. PubMed ID: 18834878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Physiopathology and clinical aspects of the alveolar surface active system (pulmonary surfactant)].
    Pescetti G; Rigamonti G; Biglino A
    Minerva Med; 1977 Aug; 68(38):2623-45. PubMed ID: 578568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CDP-choline: 6-month study on toxicity in dogs.
    Romero A; Grau T; Sacristán A; Ortiz JA
    Arzneimittelforschung; 1983; 33(7A):1038-42. PubMed ID: 6684461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Action of CDP-choline by intraduodenal route on rat cardiorespiratory system.
    Brasó MA; Sacristán A; Ortiz JA
    Arzneimittelforschung; 1983; 33(7A):1043-5. PubMed ID: 6684462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dissimilar effects in acute toxicity studies of CDP-choline and choline.
    Agut J; Font E; Sacristán A; Ortiz JA
    Arzneimittelforschung; 1983; 33(7A):1016-8. PubMed ID: 6684453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of CDP-choline administration on the aortic wall lesions in dietically hypercholesterolaemic rabbits: a morphometric evaluation.
    Weber G; Auteri A; Bianciardi G; Fabrini P; Resi L; Salvi M; Toti P; Tanganelli P
    Drugs Exp Clin Res; 1989; 15(6-7):321-3. PubMed ID: 2591303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Study of the effects of oral administration of CDP-choline on EEG changes and lethality induced by epidural compression in the anaesthetised cat.
    Algate DR; Beard DJ; Sacristán A; Ortiz JA; Davies JE
    Arzneimittelforschung; 1983; 33(7A):1013-6. PubMed ID: 6684452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological study of CDP-choline. Protection against toxicity in a model of experimental hypoxia.
    Tornos ME; Sacristán A; Ortiz JA
    Arzneimittelforschung; 1983; 33(7A):1022-4. PubMed ID: 6684455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Study on the protection of CDP-choline against nicotine intoxication.
    Grau T; Romero A; Sacristán A; Ortiz JA
    Arzneimittelforschung; 1983; 33(7A):1025-6. PubMed ID: 6684456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CDP-choline: pharmacological and clinical review.
    Secades JJ; Frontera G
    Methods Find Exp Clin Pharmacol; 1995 Oct; 17 Suppl B():1-54. PubMed ID: 8709678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Increased production of alveolar surfactant in the human fetus after treatment with cytidine diphosphocholine].
    Bracaglia R; Bellati U; Buscemi L; Riccardi P; Garzetti GG; Liverani A
    Clin Ter; 1977 Dec; 83(5):531-9. PubMed ID: 580231
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.